{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:16:06Z","timestamp":1790856966175,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1999,3,1]],"date-time":"1999-03-01T00:00:00Z","timestamp":920246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[1999,3]]},"DOI":"10.1006\/exnr.1998.7008","type":"journal-article","created":{"date-parts":[[2002,10,6]],"date-time":"2002-10-06T23:00:46Z","timestamp":1033945246000},"page":"138-148","source":"Crossref","is-referenced-by-count":168,"title":["Immunochemical Analysis of Vesicular Monoamine Transporter (VMAT2) Protein in Parkinson's Disease"],"prefix":"10.1006","volume":"156","author":[{"given":"Gary W.","family":"Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey D.","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey T.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon N.","family":"Penland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah C.","family":"Mash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Rye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan I.","family":"Levey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/exnr.1998.7008_RF1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0169-328X(94)90029-9","article-title":"Differential expression of tyrosine hydroxylase and membrane dopamine transporter genes in subpopulations of dopaminergic neurons of rat mesencephalon","volume":"22","author":"Blanchard","year":"1994","journal-title":"Mol. Brain Res."},{"key":"10.1006\/exnr.1998.7008_RF2","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/0006-291X(84)91293-2","article-title":"Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase","volume":"120","author":"Chiba","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1006\/exnr.1998.7008_RF3","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1523\/JNEUROSCI.15-03-01714.1995","article-title":"The dopamine transporter: Immunochemical characterization and localization in brain","volume":"15","author":"Ciliax","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1006\/exnr.1998.7008_RF4","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/syn.890140205","article-title":"In vivo imaging of monoaminergic nerve terminals in normal and MPTP-lesioned primate brain using positron emission tomography (PET) and [11","volume":"14","author":"Dasilva","year":"1993","journal-title":"Synapse"},{"key":"10.1006\/exnr.1998.7008_RF5","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/ana.410340504","article-title":"Neural degeneration and the transport of neurotransmitters","volume":"34","author":"Edwards","year":"1993","journal-title":"Ann. Neurol."},{"key":"10.1006\/exnr.1998.7008_RF6","doi-asserted-by":"crossref","first-page":"5166","DOI":"10.1073\/pnas.93.10.5166","article-title":"Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter","volume":"93","author":"Erickson","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/exnr.1998.7008_RF7","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1111\/j.1471-4159.1993.tb07476.x","article-title":"Functional identification and molecular cloning of a human brain vesicle monoamine transporter","volume":"61","author":"Erickson","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1006\/exnr.1998.7008_RF8","doi-asserted-by":"crossref","first-page":"10993","DOI":"10.1073\/pnas.89.22.10993","article-title":"Expression cloning of a reserpine-sensitive vesicular monoamine transporter","volume":"89","author":"Erickson","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/exnr.1998.7008_RF9","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/S0896-6273(00)80418-3","article-title":"Vesicular transport regulates monoamine storage and release but is not essential for amphetamine action","volume":"19","author":"Fon","year":"1997","journal-title":"Neuron"},{"key":"10.1006\/exnr.1998.7008_RF10","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/ana.410400609","article-title":"Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging","volume":"40","author":"Frey","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1006\/exnr.1998.7008_RF11","unstructured":"Fumagalli, F. R. R. Gainetdinov, Y. M. Wang, G. W. Miller, M. G. Caron, Increased neurotoxicity to methamphetamine in mice heterozygous for VMAT2, J. Neurosci."},{"key":"10.1006\/exnr.1998.7008_RF12","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1046\/j.1471-4159.1997.69031322.x","article-title":"Dopamine transporter is required for in vivo MPTP neurotoxicity: Evidence from mice lacking the transporter","volume":"69","author":"Gainetdinov","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1006\/exnr.1998.7008_RF13","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1046\/j.1471-4159.1998.70051973.x","article-title":"Increased MPTP neurotoxicity in vesicular monoamine transporter 2 knockout mice","volume":"70","author":"Gainetdinov","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1006\/exnr.1998.7008_RF14","first-page":"383","article-title":"Cloning, pharmacological characterization and chromosomal assignment of the human dopamine transporter","volume":"42","author":"Giros","year":"1992","journal-title":"Mol. Pharmacol."},{"key":"10.1006\/exnr.1998.7008_RF15","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/379606a0","article-title":"Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter","volume":"379","author":"Giros","year":"1996","journal-title":"Nature"},{"key":"10.1006\/exnr.1998.7008_RF16","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0306-4522(81)90131-7","article-title":"An immunohistochemical study of enkephalins and other neuropeptides in the striatum of the cat with evidence that the opiate peptides are arranged to form mosaic patterns in register with the striosomal compartments visible by acetylcholinesterase staining","volume":"6","author":"Graybiel","year":"1981","journal-title":"Neuroscience"},{"key":"10.1006\/exnr.1998.7008_RF17","first-page":"19","article-title":"Biochemical pathology of Parkinson's disease","volume":"45","author":"Hornykiewicz","year":"1986","journal-title":"Adv. Neurol."},{"key":"10.1006\/exnr.1998.7008_RF18","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1073\/pnas.82.7.2173","article-title":"Parkinsonism-inducing neurotoxin,NN","volume":"82","author":"Javitch","year":"1985","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/exnr.1998.7008_RF19","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1111\/j.1471-4159.1993.tb03521.x","article-title":"In vivo imaging of vesicular monoamine transporters in human brain using [11","volume":"60","author":"Kilbourn","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1006\/exnr.1998.7008_RF20","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0969-8051(96)00023-6","article-title":"Effects of dopaminergic drug treatments on in vivo radioligand binding to brain vesicular monoamine transporters","volume":"23","author":"Kilbourn","year":"1996","journal-title":"Nucl. Med. Biol."},{"key":"10.1006\/exnr.1998.7008_RF21","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1126\/science.1948035","article-title":"Cloning and expression of a cocaine-sensitive rat dopamine transporter","volume":"254","author":"Kilty","year":"1991","journal-title":"Science"},{"key":"10.1006\/exnr.1998.7008_RF22","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJM198804073181402","article-title":"Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease","volume":"318","author":"Kish","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/exnr.1998.7008_RF23","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1097\/00004647-199611000-00025","article-title":"Kinetic evaluation of [11","volume":"16","author":"Koeppe","year":"1996","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1006\/exnr.1998.7008_RF24","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1126\/science.6332378","article-title":"Pargyline prevents MPTP-induced parkinsonism in primates","volume":"225","author":"Langston","year":"1984","journal-title":"Science"},{"key":"10.1006\/exnr.1998.7008_RF25","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic parkinsonism in humans due to a product of meperidine analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"key":"10.1006\/exnr.1998.7008_RF26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(94)90856-7","article-title":"Monoamine vesicular uptake sites in patients with Parkinson's disease and Alzheimer's disease, as measured by tritiated dihydrotetrabenazine autoradiography","volume":"659","author":"Lehericy","year":"1994","journal-title":"Brain Res."},{"key":"10.1006\/exnr.1998.7008_RF27","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/0092-8674(92)90425-C","article-title":"A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter","volume":"70","author":"Liu","year":"1992","journal-title":"Cell"},{"key":"10.1006\/exnr.1998.7008_RF28","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/0306-4522(94)90182-1","article-title":"The organization of midbrain projections to the striatum in the primate: Sensorimotor-related striatum versus ventral striatum","volume":"59","author":"Lynd-Balta","year":"1994","journal-title":"Neurosci."},{"key":"10.1006\/exnr.1998.7008_RF29","series-title":"The Neurology Clinics","article-title":"The pathophysiology of movement disorders","author":"Marsden","year":"1984"},{"key":"10.1006\/exnr.1998.7008_RF30","unstructured":"Miller, G. W. M. L. Kirby, A. I. Levey, J. R. Bloomquist, Heptachlor alters expression and function of dopamine transporters, Neurotoxicology."},{"key":"10.1006\/exnr.1998.7008_RF31","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0076-6879(98)96029-3","article-title":"Generation of transporter specific antibodies","volume":"296","author":"Miller","year":"1998","journal-title":"Methods Enzymol."},{"key":"10.1006\/exnr.1998.7008_RF32","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/ana.410410417","article-title":"Immunochemical analysis of dopamine transporter protein in Parkinson's disease","volume":"41","author":"Miller","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1006\/exnr.1998.7008_RF33","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1523\/JNEUROSCI.16-13-04135.1996","article-title":"Ultrastructural localization of the vesicular monoamine transporter-2 in midbrain dopaminergic neurons: Potential sites of somatodendritic release of dopamine","volume":"16","author":"Nirenberg","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1006\/exnr.1998.7008_RF34","doi-asserted-by":"crossref","first-page":"6179","DOI":"10.1523\/JNEUROSCI.15-09-06179.1995","article-title":"Differential expression of two vesicular monoamine transporters","volume":"15","author":"Peter","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1006\/exnr.1998.7008_RF35","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1523\/JNEUROSCI.13-10-04246.1993","article-title":"Dopamine transporter expression confers cytotoxicity to low doses of parkinsonism-inducing neurotoxin MPTP","volume":"13","author":"Pifl","year":"1993","journal-title":"J. Neurosci."},{"key":"10.1006\/exnr.1998.7008_RF36","doi-asserted-by":"crossref","first-page":"7585","DOI":"10.1016\/S0021-9258(19)57434-8","article-title":"Energy-dependent uptake ofn","volume":"261","author":"Ramsay","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1006\/exnr.1998.7008_RF37","doi-asserted-by":"crossref","first-page":"8160","DOI":"10.1073\/pnas.84.22.8160","article-title":"Subcellular compartmentalization of 1-methyl-4-phenylpyridinium with catecholamines in adrenal medullary chromaffin vesicles may explain the lack of toxicity to adrenal chromaffin cells","volume":"84","author":"Reinhard","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/exnr.1998.7008_RF38","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/j.1471-4159.1988.tb10583.x","article-title":"[3","volume":"50","author":"Scherman","year":"1988","journal-title":"J. Neurochem."},{"key":"10.1006\/exnr.1998.7008_RF39","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1126\/science.1948034","article-title":"Cloning and expression of a cocaine-sensitive dopamine transporter cDNA","volume":"254","author":"Shimada","year":"1991","journal-title":"Science"},{"key":"10.1006\/exnr.1998.7008_RF40","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0169-328X(92)90220-6","article-title":"Dopamine transporter mRNA: Dense expression in ventral midbrain neurons","volume":"13","author":"Shimada","year":"1992","journal-title":"Mol. Brain Res."},{"key":"10.1006\/exnr.1998.7008_RF41","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0378-1119(88)90005-4","article-title":"Single-step purification of polypeptides expressed inEscherichia coliS","volume":"67","author":"Smith","year":"1988","journal-title":"Gene"},{"key":"10.1006\/exnr.1998.7008_RF42","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0006-8993(96)01196-1","article-title":"Radioligand binding and immunoautoradiographic evidence for a lack of toxicity to dopaminergic terminals in human cocaine overdose victims","volume":"747","author":"Staley","year":"1997","journal-title":"Brain Res."},{"key":"10.1006\/exnr.1998.7008_RF43","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0014-5793(93)80539-7","article-title":"A human synaptic vesicle monoamine transporter cDNA predicts post-translational modifications, reveals chromosome 10 gene localization and identifies Taq1 RFLPs","volume":"318","author":"Surratt","year":"1993","journal-title":"FEBS Lett."},{"key":"10.1006\/exnr.1998.7008_RF44","doi-asserted-by":"crossref","first-page":"9938","DOI":"10.1073\/pnas.94.18.9938","article-title":"VMAT2 knockout mice: Heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity","volume":"94","author":"Takahashi","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/exnr.1998.7008_RF45","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0006-8993(95)00674-F","article-title":"Regional distribution of monoamine vesicular uptake sites in the mesencephalon of control subjects and patients with Parkinson's disease: A postmortem study using tritiated tetrabenazine","volume":"692","author":"Thibaut","year":"1995","journal-title":"Brain Res."},{"key":"10.1006\/exnr.1998.7008_RF46","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/ana.410430503","article-title":"Hypothesis: The role of dopaminergic transporters in selective vulnerability of cells in Parkinson's disease","volume":"43","author":"Uhl","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1006\/exnr.1998.7008_RF47","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/ana.410350421","article-title":"Dopamine transporter messenger RNA in Parkinson's disease and control substantia nigra neurons","volume":"35","author":"Uhl","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1006\/exnr.1998.7008_RF48","first-page":"2252","article-title":"In vivo imaging of the brain vesicular monoamine transporter","volume":"36","author":"Vanderborght","year":"1995","journal-title":"J. Nucl. Med."},{"key":"10.1006\/exnr.1998.7008_RF49","first-page":"955","article-title":"[3","volume":"68","author":"Vanderborght","year":"1995","journal-title":"Neuroscience"},{"key":"10.1006\/exnr.1998.7008_RF50","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0896-6273(00)80419-5","article-title":"Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and hypersensitivity to cocaine and amphetamine","volume":"19","author":"Wang","year":"1997","journal-title":"Neuron"},{"key":"10.1006\/exnr.1998.7008_RF51","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1523\/JNEUROSCI.16-10-03507.1996","article-title":"The vesicular monoamine transporter, in contrast to the dopamine transporter, is not altered by chronic cocaine self-administration in the rat","volume":"16","author":"Wilson","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1006\/exnr.1998.7008_RF52","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1212\/WNL.47.3.718","article-title":"Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson's disease","volume":"47","author":"Wilson","year":"1996","journal-title":"Neurology"},{"key":"10.1006\/exnr.1998.7008_RF53","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/ana.410320120","article-title":"Parkinsonism-inducing neurotoxin MPP+: uptake and toxicity in nonneuronal COS cells expressing dopamine transporter cDNA","volume":"32","author":"Kitayama","year":"1992","journal-title":"Ann Neurol"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448869897008X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448869897008X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T06:59:11Z","timestamp":1620025151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001448869897008X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,3]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1999,3]]}},"alternative-id":["S001448869897008X"],"URL":"https:\/\/doi.org\/10.1006\/exnr.1998.7008","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[1999,3]]}}}